Article
Interstitial lung disease in inflammatory myopathies: clinical phenotypes and prognosis.
Current rheumatology reports - 1 Sept 2013
Kiely Patrick D W, Chua Felix
Abstract excerpt
Interstitial lung disease (ILD) is a very important complication of the idiopathic inflammatory myositides (IIM), with a prevalence of approximately 40 %. Characteristic HRCT changes, most commonly NSIP, together with a restrictive ventilatory defect and an associated decline in DLco support the presence of ILD. The strongest risk factors are the presence of the anti-amino-acyl-tRNA synthetases (ARS) and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
